| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Octreotide | FAERS: 4 | US FAERS | |
| 2 | Clindamycin | FAERS: 2 | US FAERS | |
| 3 | Atropine | FAERS: 1 | US FAERS | |
| 4 | Bosentan | FAERS: 1 | US FAERS | |
| 5 | Clindamycin | FAERS: 1 | US FAERS | |
| 6 | Dabigatran | FAERS: 1 | US FAERS | |
| 7 | Ibuprofen | FAERS: 1 | US FAERS | |
| 8 | Morphine | FAERS: 1 | US FAERS | |
| 9 | Naltrexone | FAERS: 1 | US FAERS | |
| 10 | Paclitaxel | FAERS: 1 | US FAERS | |
| 11 | dorzolamide-timolol combination | FAERS: 1 | US FAERS | |
| 12 | ferric gluconate | FAERS: 1 | US FAERS | |
| 13 | lanreotide | FAERS: 1 | US FAERS | |
| 14 | oxybutynin | FAERS: 1 | US FAERS | |
| 15 | ziconotide | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.